We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$39.3B
1-Year Est. Return
27.96%
This Fund
S&P 500
This Quarter
Est. Return
+13.03%
1 Year Est. Return
+27.96%
3 Year Est. Return
+58.37%
5 Year Est. Return
+80.22%
10 Year Est. Return
+439.89%
AUM
$39.3B
AUM Growth
+$3.7B
(+10%)
Cap. Flow
+$2.27B
Cap. Flow
% of AUM
5.78%
Top 10 Holdings %
Top 10 Hldgs %
11.24%
Holding
2,749
New
386
Increased
1,048
Reduced
996
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$393M |
| 2 |
AngloGold Ashanti
AU
|
+$356M |
| 3 |
General Dynamics
GD
|
+$348M |
| 4 |
NVIDIA
NVDA
|
+$202M |
| 5 |
Kroger
KR
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$441M |
| 2 |
CVS Health
CVS
|
+$424M |
| 3 |
United Parcel Service
UPS
|
+$359M |
| 4 |
Devon Energy
DVN
|
+$243M |
| 5 |
Target
TGT
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.71% |
| 2 | Miscellaneous | 16.91% |
| 3 | Healthcare | 12.7% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Communication Services | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
ATS Corp
ATS
$1.93B
| $17K | ﹤0.01% |
604
+365
| +153% | +$11.2K |
|
1327
Avalo Therapeutics
AVTX
$1.03B
| $17K | ﹤0.01% |
+942
| New | +$14.9K |
|
1328
Installed Building Products
IBP
$6.34B
| $17K | ﹤0.01% |
75
-12
| -14% | -$2.92K |
|
1329
MannKind Corp
MNKD
$1.31B
| $17K | ﹤0.01% |
+3,954
| New | +$12.8K |
|
|
JBIO
1330
Jade Biosciences
JBIO
$1.27B
| $16K | ﹤0.01% |
+712
| New | +$14.8K |
|
1331
Kura Oncology
KURA
$1.18B
| $16K | ﹤0.01% |
+1,428
| New | +$13.5K |
|
1332
Olema Pharmaceuticals
OLMA
$941M
| $16K | ﹤0.01% |
+1,261
| New | +$16.9K |
|
1333
Oric Pharmaceuticals
ORIC
$1.33B
| $16K | ﹤0.01% |
+1,516
| New | +$13.7K |
|
|
ZBIO
1334
Zenas BioPharma
ZBIO
$2.14B
| $16K | ﹤0.01% |
+626
| New | +$12.4K |
|
1335
CareDx
CDNA
$2.63B
| $15K | ﹤0.01% |
+531
| New | +$11.6K |
|
1336
Vor Biopharma
VOR
$1.48B
| $15K | ﹤0.01% |
+815
| New | +$12.3K |
|
1337
Xencor
XNCR
$1.98B
| $15K | ﹤0.01% |
+901
| New | +$11.3K |
|
|
BCAX
1338
Bicara Therapeutics
BCAX
$1.53B
| $15K | ﹤0.01% |
+509
| New | +$11.4K |
|
1339
Brady Corp
BRC
$4.23B
| $14K | ﹤0.01% |
149
-36
| -19% | -$2.99K |
|
1340
CytomX Therapeutics
CTMX
$808M
| $14K | ﹤0.01% |
+3,697
| New | +$14.1K |
|
1341
Clearway Energy Class C
CWEN
$6.53B
| $14K | ﹤0.01% |
422
-843,799
| -100% | -$32.7M |
|
1342
Janux Therapeutics
JANX
$1.24B
| $14K | ﹤0.01% |
+895
| New | +$13K |
|
1343
Replimune Group
REPL
$1.42B
| $14K | ﹤0.01% |
+1,275
| New | +$7.8K |
|
1344
ArriVent BioPharma
AVBP
$1.53B
| $14K | ﹤0.01% |
+407
| New | +$12K |
|
1345
CorVel
CRVL
$3.45B
| $13K | ﹤0.01% |
201
-27
| -12% | -$1.57K |
|
1346
Geron
GERN
$1.01B
| $13K | ﹤0.01% |
+10,128
| New | +$14.3K |
|
1347
Organon & Co
OGN
$3.62B
| $13K | ﹤0.01% |
978
-236
| -19% | -$2.82K |
|
1348
Western Union
WU
$2.24B
| $13K | ﹤0.01% |
+1,649
| New | +$13.8K |
|
|
SION
1349
Sionna Therapeutics
SION
$325M
| $13K | ﹤0.01% |
+301
| New | +$12K |
|
1350
Enact Holdings
ACT
$6.77B
| $12K | ﹤0.01% |
267
-66
| -20% | -$2.82K |
|
Similar funds
PPF
CS
Pacer Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Pacer Advisors held 2,749 positions worth $39.3B, up 10% from $35.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Pacer Advisors deployed $2.27B of net new capital in Q2 2026, opening 386 new positions and adding to 1,048 existing holdings. Its largest new stake was AngloGold Ashanti: 3,744,168 shares worth $303M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was ConocoPhillips, an estimated $441M trimmed.
- Pacer Advisors's largest Q2 2026 buy was AngloGold Ashanti: 3,744,168 shares worth $303M.
- Pacer Advisors added most to Lowe's Companies in Q2 2026, an estimated $393M increase.
- Pacer Advisors's biggest Q2 2026 reduction was ConocoPhillips, cutting an estimated $441M.
- Pacer Advisors fully exited Coterra Energy in Q2 2026, selling an estimated $118M.
- Pacer Advisors's ten largest holdings make up 11% of its $39.3B portfolio in Q2 2026.
- Pacer Advisors opened 386 new positions and closed 125 in Q2 2026.
- Pacer Advisors's portfolio value rose 10% quarter-over-quarter to $39.3B.
Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.